On Tuesday, Neuronetics Inc (NASDAQ: STIM) opened higher 2.83% from the last session, before settling in for the closing price of $2.83. Price fluctuations for STIM have ranged from $0.52 to $5.92 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 2.71% over the past five years. Company’s average yearly earnings per share was noted 58.12% at the time writing. With a float of $40.41 million, this company’s outstanding shares have now reached $66.11 million.
Let’s look at the performance matrix of the company that is accounted for 716 employees.
Neuronetics Inc (STIM) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Neuronetics Inc is 38.89%, while institutional ownership is 27.73%. The most recent insider transaction that took place on Aug 08 ’25, was worth 13,020,000. In this transaction 10% Owner of this company sold 3,500,000 shares at a rate of $3.72, taking the stock ownership to the 1,142,351 shares. Before that another transaction happened on Aug 08 ’25, when Company’s 10% Owner proposed sale 2,925,554 for $3.72, making the entire transaction worth $10,883,061.
Neuronetics Inc (STIM) Latest Financial update
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.44 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.23) by -0.21. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.12% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.10% during the next five years compared to 2.71% growth over the previous five years of trading.
Neuronetics Inc (NASDAQ: STIM) Trading Performance Indicators
Check out the current performance indicators for Neuronetics Inc (STIM). In the past quarter, the stock posted a quick ratio of 1.84. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.73.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.13, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.44 in one year’s time.
Technical Analysis of Neuronetics Inc (STIM)
Neuronetics Inc (NASDAQ: STIM) saw its 5-day average volume 1.06 million, a negative change from its year-to-date volume of 1.25 million. As of the previous 9 days, the stock’s Stochastic %D was 66.28%.
During the past 100 days, Neuronetics Inc’s (STIM) raw stochastic average was set at 14.73%, which indicates a significant decrease from 77.01% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.18 in the past 14 days, which was lower than the 0.25 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.38, while its 200-day Moving Average is $3.59. Nevertheless, the first resistance level for the watch stands at $2.98 in the near term. At $3.04, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.12. If the price goes on to break the first support level at $2.84, it is likely to go to the next support level at $2.76. The third support level lies at $2.70 if the price breaches the second support level.
Neuronetics Inc (NASDAQ: STIM) Key Stats
There are currently 66,125K shares outstanding in the company with a market cap of 192.42 million. Presently, the company’s annual sales total 74,890 K according to its annual income of -43,710 K. Last quarter, the company’s sales amounted to 38,110 K and its income totaled -10,120 K.
